Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 16/20 | 0.87 |
| ▸ | NTSR2 | O95665 | 15/20 | 0.87 |
| ▸ | SORT1 | Q99523 | 12/20 | 0.87 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416842 | 1.00 | NTSR1 (0.87) | NTSR1NTSR2SORT1 | |
| SCHEMBL29398203 | 1.00 | NTSR1 (0.87) | NTSR1NTSR2SORT1 | |
| SCHEMBL29930119 | 0.94 | NTSR1 (0.87) | NTSR1NTSR2SORT1 | |
| SCHEMBL30880437 | 0.91 | NTSR1 (0.82) | NTSR1NTSR2SORT1 | |
| SCHEMBL31280899 | 0.90 | NTSR1 (0.74) | NTSR1NTSR2SORT1 | |
| SCHEMBL29361023 | 0.90 | NTSR1 (0.74) | NTSR1NTSR2SORT1 | |
| SCHEMBL30034783 | 0.89 | NTSR2 (0.73) | NTSR1NTSR2SORT1 | |
| SCHEMBL30037824 | 0.89 | NTSR2 (0.73) | NTSR1NTSR2SORT1 | |
| SCHEMBL29533517 | 0.88 | NTSR1 (0.82) | NTSR1NTSR2SORT1 | |
| Proctolin SCHEMBL30163458 | 0.87 | NTSR1 (0.71) | NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382633-A1 | ADENOVIRAL VECTORS | UNIV ZUERICH (CH) | 2025-12-18 | — | — | US | disclosed |
| EP-4453224-A1 | ADENOVIRAL VECTORS | Universität Zürich (CH) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023235921-A1 | METHODS FOR PRODUCING POLYPEPTIDE VARIANTS | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023117987-A1 | ADENOVIRAL VECTORS | Universität Zürich (CH) | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382633-A1 | ADENOVIRAL VECTORS | DARS1, DBN1, DBNL | NTSR1 2854/4885NTSR2 3498/4885SORT1 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.